Disruption of adiponectin leads to high-fat diet–induced insulin resistance and levels are low in humans with obesity and insulin resistance while adiponectin levels are increased by insulin-sensitizing peroxisome proliferator-activated receptors (PPAR)γ agonists. The gene discussed is ADIPOQ; the disease is Obesity.